Supply Chain Interruptions/ Recalls

Supply Chain Interruptions/ Recalls

Welcome to our dedicated page for Supply Chain Interruptions and Recalls in the dialysis industry. Here, you'll find the latest updates and critical information about disruptions and recalls affecting dialysis supplies and equipment. Our goal is to keep you informed and prepared, ensuring that you can manage your operations smoothly and maintain the highest standards of patient care despite unforeseen challenges. 

Last updated 9/17/25.

CLICK HERE TO SUBMIT UPDATES 

.

Recalls

September 12: BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets

June 13: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination 

May 22: Nipro - Voluntary Recall of all lots of BC+ 201, 45x MedicaLyte Liquid Bicarbonate Jugs

.

Corrections

August 15: KCER - FDA Early Alert: Infusion Pump Issue from Baxter

• The FDA is aware that Baxter has issued a letter to affected customers recommending all Novum IQ Large
  Volume Pumps (LVP) and Novum IQ Syringe Pumps (SP) be corrected prior to continued use.

.

Interruptions

September 10: Early Alert: TactiFlex Ablation Catheter Issue from Abbott

• The FDA is aware that Abbott has issued a letter to affected customers recommending updated instructions when removing the TactiFlex Ablation Catheter, Sensor Enabled from its packaging.

.

Discontinuations

July 17: Watson Pharma Private Limited, Potassium Citrate Tablet, Extended Release

June 10: Fresenius Medical Care, Sodium Chloride 0.9% Injection

May 14: Upsher-Smith Laboratories, LLC, Oxybutynin Chloride, Tablet, 5 mg

.

Monitoring: PD Fluid Shortage

• July 7 (Revised): Baxter
  • Baxter PD List of NDCs - Available.
• July 7 (Revised): Fresenius Medical
  • Fresenius PD List of NDCs - Available
• FDA - Peritoneal Dialysis Solution Updates

.

Drug Shortages

July 10 (Revised): Hospira, Dubutamine Hydrochloride Injection. Limited Availability or Unavailable. 

Unavailable

• 1,000 mg/250mL: Next delivery Nov. 2025. Estimated recovery Dec. 2025.
• 250 mg/250mL in Dextrose 5%: Next delivery & estimated recovery Dec. 2026. 
• 500 mg/250mL: Next delivery Nov. 2025. Estimated recovery Dec. 2025.
• 250 mg/20mL (NDC 0409-2344-88): Next delivery and estimated recovery Dec. 2028.

Limited Availability

• 250 mg/20mL (NDC 0409-2344-01): Next delivery and estimated recovery Mar. 2026.
• 250 mg/20mL (NDC 0409-2344-02): Next delivery and estimated recovery Jun. 2025.

July 10 (Revised): Hospira, Hydrocortisone Sodium Succinate Injection. Limited Availability.

.

.

If you have information on a dialysis-related supply chain interruption, recall, correction, shortage, or discontinuation, please submit here.

If you have any questions, please contact marketing@renalhealthcare.org.

.